Literature DB >> 30593508

Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of nonmalignant cells.

Chia-Hao Wu1, Christopher R Silvers2, Edward M Messing2, Yi-Fen Lee3,2.   

Abstract

The field cancerization effect has been proposed to explain bladder cancer's multifocal and recurrent nature, yet the mechanisms of this effect remain unknown. In this work, using cell biology, flow cytometry, and qPCR analyses, along with a xenograft mouse tumor model, we show that chronic exposure to tumor-derived extracellular vesicles (TEVs) results in the neoplastic transformation of nonmalignant human SV-HUC urothelial cells. Inhibition of EV uptake prevented this transformation. Transformed cells not only possessed several oncogenic properties, such as increased genome instability, loss of cell-cell contact inhibition, and invasiveness, but also displayed altered morphology and cell structures, such as an enlarged cytoplasm with disrupted endoplasmic reticulum (ER) alignment and the accumulation of smaller mitochondria. Exposure of SV-HUC cells to TEVs provoked the unfolded protein response in the endoplasmic reticulum (UPRER). Prolonged induction of UPRER signaling activated the survival branch of the UPRER pathway, in which cells had elevated expression of inositol-requiring enzyme 1 (IRE1), NF-κB, and the inflammatory cytokine leptin, and incurred loss of the pro-apoptotic protein C/EBP homologous protein (CHOP). More importantly, inhibition of ER stress by docosahexaenoic acid prevented TEV-induced transformation. We propose that TEVs promote malignant transformation of predisposed cells by inhibiting pro-apoptotic signals and activating tumor-promoting ER stress-induced unfolded protein response and inflammation. This study provides detailed insight into the mechanisms underlying the bladder cancer field effect and tumor recurrence.
© 2019 Wu et al.

Entities:  

Keywords:  bladder cancer; cell stress; cytokine; endoplasmic reticulum stress (ER stress); exosome (vesicle); extracellular vesicles; filed cancerization; inflammation; unfolded protein response (UPR); urothelial carcinoma

Mesh:

Substances:

Year:  2018        PMID: 30593508      PMCID: PMC6398136          DOI: 10.1074/jbc.RA118.006682

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Biochemical basis of oxidative protein folding in the endoplasmic reticulum.

Authors:  B P Tu; S C Ho-Schleyer; K J Travers; J S Weissman
Journal:  Science       Date:  2000-11-24       Impact factor: 47.728

2.  Large block embedding and "pop-off" technique for immunoelectron microscopy.

Authors:  K L de Mesy Jensen; P A di Sant'Agnese
Journal:  Ultrastruct Pathol       Date:  1992 Jan-Apr       Impact factor: 1.094

Review 3.  Membrane vesicles as conveyors of immune responses.

Authors:  Clotilde Théry; Matias Ostrowski; Elodie Segura
Journal:  Nat Rev Immunol       Date:  2009-06-05       Impact factor: 53.106

4.  Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes.

Authors:  Zakaria Y Abd Elmageed; Yijun Yang; Raju Thomas; Manish Ranjan; Debasis Mondal; Krzysztof Moroz; Zhide Fang; Bashir M Rezk; Krishnarao Moparty; Suresh C Sikka; Oliver Sartor; Asim B Abdel-Mageed
Journal:  Stem Cells       Date:  2014-04       Impact factor: 6.277

5.  Loss of mitofusin 2 promotes endoplasmic reticulum stress.

Authors:  Gladys A Ngoh; Kyriakos N Papanicolaou; Kenneth Walsh
Journal:  J Biol Chem       Date:  2012-04-17       Impact factor: 5.157

6.  Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis.

Authors:  Firas Abdollah; Giorgio Gandaglia; Rodolphe Thuret; Jan Schmitges; Zhe Tian; Claudio Jeldres; Niccolò Maria Passoni; Alberto Briganti; Shahrokh F Shariat; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz; Maxine Sun
Journal:  Cancer Epidemiol       Date:  2013-02-26       Impact factor: 2.984

7.  Microvesicle Cargo and Function Changes upon Induction of Cellular Transformation.

Authors:  Bridget T Kreger; Andrew L Dougherty; Kai Su Greene; Richard A Cerione; Marc A Antonyak
Journal:  J Biol Chem       Date:  2016-07-20       Impact factor: 5.157

8.  Omega-3 fatty acids inhibit tumor growth in a rat model of bladder cancer.

Authors:  Belmiro Parada; Flávio Reis; Raquel Cerejo; Patrícia Garrido; José Sereno; Maria Xavier-Cunha; Paula Neto; Alfredo Mota; Arnaldo Figueiredo; Frederico Teixeira
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411

9.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.

Authors:  Johan Skog; Tom Würdinger; Sjoerd van Rijn; Dimphna H Meijer; Laura Gainche; Miguel Sena-Esteves; William T Curry; Bob S Carter; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Cell Biol       Date:  2008-11-16       Impact factor: 28.824

10.  Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells.

Authors:  Sujoy Dutta; Case Warshall; Chirosree Bandyopadhyay; Dipanjan Dutta; Bala Chandran
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

View more
  22 in total

Review 1.  The multiple roles of the unfolded protein response regulator IRE1α in cancer.

Authors:  Fiona Chalmers; Saie Mogre; Jeongin Son; Nicholas Blazanin; Adam B Glick
Journal:  Mol Carcinog       Date:  2019-04-30       Impact factor: 4.784

2.  Agonist-induced extracellular vesicles contribute to the transfer of functional bombesin receptor-subtype 3 to recipient cells.

Authors:  Zeyuan Wang; Lehao Wu; Huiyu Wang; Yan Zhang; Hua Xiao
Journal:  Cell Mol Life Sci       Date:  2022-01-15       Impact factor: 9.261

Review 3.  Contribution of Tumor-Derived Extracellular Vesicles to Malignant Transformation of Normal Cells.

Authors:  Daria S Chulpanova; Tamara V Pukhalskaia; Albert A Rizvanov; Valeriya V Solovyeva
Journal:  Bioengineering (Basel)       Date:  2022-06-04

4.  Exosomes in bladder cancer: novel biomarkers and targets.

Authors:  Hao Geng; Qingchen Zhou; Wenhao Guo; Ling Lu; Liangkuan Bi; Yi Wang; Jie Min; Dexin Yu; Zhaofeng Liang
Journal:  J Zhejiang Univ Sci B       Date:  2021-05-15       Impact factor: 3.066

Review 5.  Extracellular Vesicles as Transmitters of Hypoxia Tolerance in Solid Cancers.

Authors:  Marijke I Zonneveld; Tom G H Keulers; Kasper M A Rouschop
Journal:  Cancers (Basel)       Date:  2019-01-29       Impact factor: 6.639

6.  Enhanced metastatic potential in the MB49 urothelial carcinoma model.

Authors:  Yu-Ru Liu; Peng-Nien Yin; Christopher R Silvers; Yi-Fen Lee
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

7.  Exosomes derived from HeLa cells break down vascular integrity by triggering endoplasmic reticulum stress in endothelial cells.

Authors:  Yinuo Lin; Chi Zhang; Pingping Xiang; Jian Shen; Weijian Sun; Hong Yu
Journal:  J Extracell Vesicles       Date:  2020-02-03

Review 8.  Extracellular vesicles in urological malignancies.

Authors:  Michael P Rimmer; Christopher D Gregory; Rod T Mitchell
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-05-19       Impact factor: 10.680

9.  Hypoxia-Induced Adaptations of miRNomes and Proteomes in Melanoma Cells and Their Secreted Extracellular Vesicles.

Authors:  Geoffroy Walbrecq; Odile Lecha; Anthoula Gaigneaux; Miriam R Fougeras; Demetra Philippidou; Christiane Margue; Milène Tetsi Nomigni; François Bernardin; Gunnar Dittmar; Iris Behrmann; Stephanie Kreis
Journal:  Cancers (Basel)       Date:  2020-03-14       Impact factor: 6.639

10.  Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging.

Authors:  Stefanie Hiltbrunner; Michael Mints; Maria Eldh; Robert Rosenblatt; Benny Holmström; Farhood Alamdari; Markus Johansson; Rosanne E Veerman; Ola Winqvist; Amir Sherif; Susanne Gabrielsson
Journal:  Sci Rep       Date:  2020-04-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.